2005
DOI: 10.1172/jci23962
|View full text |Cite|
|
Sign up to set email alerts
|

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Abstract: During the preparation of the manuscript, the file conversion process led to the introduction of errors in the Methods section. The correct temperatures and procedures are listed below.Measurement of desaturation index. Fatty acid methyl esters were identified with an Agilent 6890 gas chromatograph connected to an HP-5 column (30 m × 0.32 mm × 0.25 µM film thickness) connected to a flame ionization detector set at 250°C. The column and the injector temperature were set to 50°C. The column temperature was incre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
114
3

Year Published

2005
2005
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 137 publications
(130 citation statements)
references
References 37 publications
(41 reference statements)
12
114
3
Order By: Relevance
“…Whereas short-term treatment with an antisense inhibitor of Scd1 is sufficient to improve hepatic insulin sensitivity (46), longer treatment additionally prevents diet-induced obesity and is associated with lowered plasma glucose and insulin (47). For the first time, using the hyperinsulinemic-euglycemic clamp technique, we show that insulin-stimulated whole-body, heart, and soleus muscle glucose uptake are increased in Scd1 Ϫ/Ϫ mice.…”
Section: Scd1 Deficiency In Obese Micementioning
confidence: 80%
“…Whereas short-term treatment with an antisense inhibitor of Scd1 is sufficient to improve hepatic insulin sensitivity (46), longer treatment additionally prevents diet-induced obesity and is associated with lowered plasma glucose and insulin (47). For the first time, using the hyperinsulinemic-euglycemic clamp technique, we show that insulin-stimulated whole-body, heart, and soleus muscle glucose uptake are increased in Scd1 Ϫ/Ϫ mice.…”
Section: Scd1 Deficiency In Obese Micementioning
confidence: 80%
“…There is strong evidence that downregulation of SCD1 prevents or reduces the development of NAFLD, obesity and insulin resistance [29][30][31][32]. Elevated hepatic transcription of Scd1 has been reported in fat-fed mice of the 129S6 [13] and C57BL/6J [13,23] strains.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, although thiazolidinediones enhanced adipocyte conversion, they concomitantly caused a dramatic decrease in cell size and lipid droplet compared with the control 3T3-L1 cells. SCD1 inhibition has been suggested as a new target for the treatment of obesity and related metabolic disorders (32)(33)(34). SCD1 is a key rate-limiting enzyme in the synthesis of unsaturated fatty acids, major components of triacylglycerols, from long-chain saturated fatty acids.…”
Section: Discussionmentioning
confidence: 99%